We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
As regulations increase across the pharmaceutical industry, reliable scientific evidence is needed to support the decisions being made during the drug development process in order to achieve the safe delivery of medicines to patients.
Recent regulations around issues such as particulate and heavy metals, require a strong understanding of the testing and analysis to move drug products to the market.
Collaboration with strategic suppliers is critical to managing issues associated with bringing a sensitive drug molecule to market. By supporting our customers from molecule to market, West works to build a close partnership that can provide the scientific analysis, data and regulatory support needed to mitigate risk, speed drug development, and get drug products to market to support patient health.
No matter what challenges our customers face during the drug product life-cycle, chances are West has faced them before. With nearly a century of industry leading experience, West may already have the answers you need, and if not, we can develop a scientific approach to find what you’re looking for. Working together, we can address issues quickly and effectively, helping to mitigate risks as early as possible in the development process by helping customers navigate regulatory and technical challenges.
To learn more about how West can help, check out our video here on our Integrated Solutions Program page.#WestByYourSide
Today, West Pharmaceutical Services welcomed the Southeast PA Regional Veterans Consortium to its Exton, PA headquarters. The Consortium, created to bring together top employers to collectively combat the employment issues that veterans face, shares West’s dedication to this important cause.
According to the Code of Federal Regulations Title 21 Food and Drugs Part 211.94(a) Subpart E Control of Components and Drug Product Containers and Closures, drug containers must not react or add to a drug product in a way that alters the drug’s safety or quality.
As this year’s annual West without Borders campaign begins to wind down, West colleagues at the Exton, Pa., headquarters spent June 22 at the Lionville YMCA raising funds for <a href="http://cure4cam.org/"><span style="color: #0000ff; text-decoration: underline;">Cure4Cam</span></a> and <a href="http://www.miracleinmotion.org/Home_Page.php"><span style="color: #0000ff; text-decoration: underline;">Miracle in Motion</span></a>.
When the COVID-19 Pandemic shut down the ability for in-person tradeshows and events, we worked to find an alternative solution with a new virtual exhibit designed to replicate the West experience without the risk of in-person interactions. Our team members quickly turned the idea of a booth replacement into an interactive experience for customers to use – both during trade shows and any time there’s a need to connect with us.
<p>We are proud to announce our inaugural Corporate Responsibility Report. West’s commitment to sustainability and remaining active in the areas where we live and work are integral to West’s culture. In Parts 1-3 of this five-part blog series on the report, we focused on West’s efforts in <a href="/blog/2017/june/corporate-responsibility-for-2016">Compliance and Ethics</a>, <a href="/blog/2017/july/corporate-responsibility-report-part-2-philanthropy">Philanthropy</a> and <a href="/blog/2017/july/corporate-responsibility-report-part-3-celebrating-diversity">Diversity</a>.</p><p>The fourth part of the five-part series on West’s Corporate Responsibility discusses West’s Health and Safety programs.</p>
English
Chinese
